Key Market Indicators
Antacid medicine sales in Slovakia are expected to reach $1.02 million by 2026. In 2021, sales were $990,000, with an average annual growth rate of 0.8%. Since 2001, the Slovak market has declined by an average of 0.2% each year. In 2021, the country ranked 17th in the world. Slovenia overtook Slovakia with $990,000 in sales. Italy, Germany, and Chile ranked second, third, and fourth, respectively.
